Other Income & Expense
Interest Expense
Vertex Pharmaceuticals Interest Expense remained flat by 0.0% to $3.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 86.0%, from $23.60M to $3.30M. Over 4 years (FY 2021 to FY 2025), Interest Expense shows an upward trend with a -31.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
Increasing interest expense may signal higher debt levels or rising interest rates, which can reduce net profitability.
Detailed definition
Interest expense represents the cost incurred by a company for borrowed funds, such as loans, bonds, or other debt instr...
Peer comparison
Highly dependent on the company's capital structure; peers with lower debt-to-equity ratios will show lower interest expenses.
Metric ID:
is_interest_expenseHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$15.48M | -$15.26M | -$15.09M | -$14.90M | -$14.60M | -$13.70M | -$11.60M | -$11.40M | -$11.20M | -$10.90M | -$10.60M | -$10.40M | $9.90M | $7.50M | $23.60M | $3.00M | $3.70M | $3.30M | $3.30M |
| QoQ Change | — | +1.4% | +1.1% | +1.3% | +2.0% | +6.2% | +15.3% | +1.7% | +1.8% | +2.7% | +2.8% | +1.9% | +195.2% | -24.2% | +214.7% | -87.3% | +23.3% | -10.8% | +0.0% |
| YoY Change | — | — | — | — | +5.7% | +10.2% | +23.1% | +23.5% | +23.3% | +20.4% | +8.6% | +8.8% | +188.4% | +168.8% | +322.6% | +128.8% | -62.6% | -56.0% | -86.0% |
Range-$15.48M – $23.60M
CAGR-29.1%
Avg YoY Growth+48.5%
Median YoY Growth+20.4%
Interest Expense at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's interest expense?
- Vertex Pharmaceuticals (VRTX) reported interest expense of $3.30M in Q4 2025.
- How has Vertex Pharmaceuticals's interest expense changed year-over-year?
- Vertex Pharmaceuticals's interest expense decreased by 86.0% year-over-year, from $23.60M to $3.30M.
- What is the long-term trend for Vertex Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's interest expense has grown at a -31.8% compound annual growth rate (CAGR), from -$61.50M to $13.30M.
- What does interest expense mean?
- The cost of borrowing money, paid as interest on debt.